Ranitidine Products Linked to Cancer Risk
Have you or a loved one taken Zantac and subsequently suffered bladder cancer, pancreatic cancer (pancreatitis), stomach cancer, brain cancer, or other cancers and injuries?
You may be entitled to compensation for your injuries through the Zantac Lawsuit.
Contact TorHoerman Law today to discuss your legal options with an experienced Zantac lawyer, free of charge and no obligation required.
If you do not qualify for a Zantac cancer lawsuit, you may still qualify for a Zantac class-action lawsuit if you took Zantac and were unaware of the cancer risks associated with the drug.
Want a faster analysis to see if you qualify for a Zantac lawsuit?
Use our chatbot below to get an instant online case evaluation free of charge.
The Zantac lawsuit is a legal claim filed against the manufacturers of Ranitidine and Zantac for their alleged link to cancer.
NDMA, a known carcinogen, may be the cause of stomach, liver, and bladder cancer after taking Zantac or Ranitidine.
Zantac is the trade name for Ranitidine, a popular heartburn medication that reduces the body’s production of stomach acid.
The medication is commonly used to treat and prevent ulcers of the stomach and intestines as well as:
Zantac is available both over-the-counter and by prescription.
Ranitidine belongs to the h2 (histamine-2) blockers class of drugs.
Zantac OTC is most commonly used to relieve and prevent heartburn, while the prescription-strength drug is used to prevent more serious ulcers and conditions.
The drug came into commercial use in 1981 and is now the 50th most prescribed medication in the United States.
Zantac is used to prevent and relieve:
Zantac is also used to reduce stomach acid production, with the intention of treating:
If you or a loved one previously used Zantac or similar products and were subsequently diagnosed with cancer, you may qualify to file a Zantac lawsuit.
Contact TorHoerman Law for a free, no-obligation case consultation with a Zantac cancer lawyer to discuss your legal options today.
Want to find out if you qualify for compensation right away?
Use our chatbot below to receive a free, instant online case evaluation right now!
In early 2020 it was revealed that the popular heartburn medication Zantac contained a cancer-causing chemical.
NDMA, scientifically known as N-nitrosodimethylamine, is an organic compound that has been linked to numerous types of cancer including:
Research has not found a definitive answer, but some studies suggest that Zantac may play a role in the development of prostate cancer.
One study found that men taking Zantac had a slightly increased risk of developing prostate cancer.
Zantac contains the substance NDMA which has been linked to a number of cancers.
Rather than list them all, here are the fifteen (15) most common types of cancer that Zantac has been linked to:
Since the FDA issued a recall of all prescription and over-the-counter versions of Zantac in April 2020, the original drug is no longer available for purchase in the United States.
The U.S. Food and Drug Administration (FDA) issued a recall of all prescription and over-the-counter versions of Zantac in April 2020 after it was revealed that the popular heartburn medication contained a cancer-causing chemical.
The main injury claimed in Zantac and ranitidine lawsuits is cancer.
The FDA warned that the high levels of NDMA in Zantac posed a “potential cancer risk” to users.
Zantac recalls from various companies began in September 2019.
However, the FDA ordered a market withdrawal in April 2020.
Yes, this drug has been brought back to pharmacies, albeit with a different ingredient called famotidine.
The Zantac 360 is the same as the former and has no known connection to cancer.
Zantac became available over-the-counter in 2004.
The FDA first approved the drug in 1983 for prescription use.
Yes, the new Zantac is safe.
The FDA has cleared the drug for use and there have been no reports of cancer or other serious side effects.
Yes, pregnant women can take Zantac.
The FDA has classified the drug as pregnancy category B – which means it is not expected to be harmful to an unborn baby.
The expected Zantac payout from a Zantac lawsuit would include the total economic damages that you have already incurred, any expected future economic damages, and non-economic damages such as pain & suffering.
Based on current Zantac payout amounts, plaintiffs can expect to receive between $20,000 to $400,000 in Zantac cancer claims and compensation.
However, this range of compensation is not a guarantee, nor is any compensation guaranteed.
If you’d like to learn if you qualify to be a plaintiff in the Zantac Lawsuits, please contact us today!
There is no set date for the Zantac lawsuit to be settled.
However, it is expected that a settlement will be reached in late 2022.
The most recent update in the Zantac Lawsuit entails a finalization date for short-form complaints against brand-name Ranitidine/Zantac manufacturers and the registry those complaints are contained in.
The Zantac Lawsuit is also commonly known as the Zantac Multidistrict Litigation (MDL).
The District Judge presiding over the Zantac MDL in the Southern District of Florida has set the final date for short-form complaints and additions to the registry as June 30th, 2022.
The registry was created through a court order in September 2020, seven months after the MDL was formed.
The registry’s purpose is to organize the litigation, helping to identify which claimants shall be used as bellwether cases and collecting detailed case information to refer to for settlements.
In early 2020 it was revealed that the popular heartburn medication Zantac contained a cancer-causing chemical.
NDMA, scientifically known as N-nitrosodimethylamine, is an organic compound that has been linked to numerous types of cancer including:
Research found NDMA in Zantac’s active ingredient, Ranitidine.
The U.S. Food and Drug Administration (FDA) warning says NDMA was found at levels between 3,000 to 26,000 times higher than FDA approved standards.
These high levels of NDMA put users at a higher risk of cancer.
The FDA acceptable threshold of daily NDMA intake is set at below 100 nanograms. The plaintiffs cited a study that claims that a 150-milligram pill of Zantac contains over 2.5 million nanograms of NDMA.
The FDA formally recalled and requested the removal of all Ranitidine products from shelves, and now the producers of Ranitidine and Zantac face lawsuits from hundreds of thousands of claimants.
Zantac MDL bellwether trials are estimated to take place in summer 2023.
The first Zantac trial will be brought in front of a jury on October 10, 2022 under California’s version of multidistrict litigation, called Judicial Council Coordinated Proceedings (JCCP).
The California trial will be a good indication on how bellwether trials in the Zantac MDL may pan out.
Research revealed that the primary active ingredient in Zantac and similar generic products, ranitidine, contains high levels of NDMA, a possible chemical carcinogen.
NDMA, scientifically known as N-nitrosodimethylamine, is an organic compound found at low levels in:
Scientists have found high levels of NDMA, according to FDA standards, in multiple pharmaceuticals which have consistently exposed consumers to the chemical.
Manufacturers failed to warn consumers that Zantac contained NDMA, putting consumers at risk of cancer.
The U.S. Food and Drug Administration (FDA) reported an advisory on September 13, 2019, after discovering the carcinogenic contaminant NDMA in ranitidine, the active ingredient in Zantac, at levels between 3,000 to 26,000 times higher than FDA approved standards.
These high levels of NDMA put users at a higher risk of cancer.
The FDA acceptable threshold of daily NDMA intake is set at below 100 nanograms.
The plaintiffs cited a study that claims that a 150-milligram pill of Zantac contains over 2.5 million nanograms of NDMA.
Over-the-counter Zantac is typically sold in 150-milligram tablets - the recommended dosage to treat peptic ulcer disease for adults is 300 milligrams a night for four to eight weeks.
Plaintiffs allege that Sanofi and Boehringer Ingleham knew the risks of NDMA formation in ranitidine and did not alert the public through the drug’s label or through any other means.
Several published studies have shown that generic ranitidine users have a 400-fold increase of NDMA concentration in their urine.
The suit attests that had consumers known the risks, they would not have purchased or consumed ranitidine.
These are the nine (9) most common Zantac products and generic Zantac products containing ranitidine:
Zantac and other ranitidine-containing products may put consumers at risk of a number of adverse health risks including cancer.
NDMA, n-nitrosodimethylamine, is a potential hepatotoxic, and exposure has been linked to numerous serious complications and symptoms ranging from:
Other symptoms of NDMA exposure include:
The World Health Organization described NDMA as a chemical that is “clearly carcinogenic.”
The FDA is working alongside regulators and industry partners to discover the source of impurities in ranitidine.
The FDA is examining ranitidine NDMA levels and evaluating the potential risk to patients.
The investigation is ongoing, and the agency plans to take appropriate measures.
Plaintiffs in the Zantac suit have a variety of cancers, including:
The FDA issued a recall of all prescription and over-the-counter versions of Zantac in April 2020.
After determining the high levels of NDMA to be dangerous to consumers, the FDA called for patients to stop taking ranitidine.
Further, the FDA has requested that the manufacturers recall the product and discontinue production of both Zantac and generic Zantac drugs.
Prior to this decision, some companies such as CVS, Walmart, and Sandoz have chosen to voluntarily suspend the sales of Zantac while waiting for results from ongoing tests and research.
Both class-action lawsuits and civil lawsuits have been filed against the manufacturers of Zantac.
These are separate types of lawsuits.
It is important that you recognize which legal action is most appropriate for you before pursuing a Zantac lawsuit.
For assistance in determining your best legal action, contact TorHoerman Law for a free, no-obligation case consultation.
The makers of Zantac, a popular over-the-counter and prescription heartburn medication, are facing a Zantac class-action lawsuit claiming the drug contains unsafe levels of the cancer-causing substance N-Nitrosodimethylamine (NDMA).
The FDA reported an advisory on September 13, 2019, after discovering the carcinogenic contaminant NDMA in ranitidine, the active ingredient in Zantac, at levels between 3,000 to 26,000 times higher than FDA approved standards.
NDMA is a potential hepatotoxic, and exposure has been linked to numerous complications and symptoms including, but not limited to:
Other symptoms of NDMA exposure include:
Plaintiffs accuse drugmakers Sanofi and Boehringer Ingelheim of manufacturing and marketing a medication they knew, or should have known, to be contaminated with the cancer-causing chemical without disclosing the risks to consumers or the government.
The CAL has been filed against the manufacturers for concealing adverse health risks associated with Zantac that led plaintiffs to suffer serious injury and death.
NOTICE: TorHoerman Law is not involved in the Zantac CAL.
The makers of Zantac, a popular heartburn medication, are facing lawsuits claiming the drug contains unsafe levels of the cancer-causing substance N-Nitrosodimethylamine (NDMA) which caused plaintiffs to develop cancer.
Plaintiffs accuse drugmakers Sanofi and Boehringer Ingelheim of manufacturing and marketing a medication they knew, or should have known, to be contaminated with the cancer-causing chemical without disclosing the risks to consumers or the government.
The manufacturer’s failure to warn directly lead to plaintiffs developing a number of life-threatening types of cancer after taking Zantac.
A Zantac MDL has been filed on behalf of individuals who have been diagnosed with cancer as a result of taking Zantac.
All similar Zantac cancer lawsuits will be consolidated into this MDL.
Notice: TorHoerman Law is involved in the Zantac Cancer Lawsuit.
Our firm is currently accepting new clients for the Zantac Lawsuit.
If you believe that you have a case, contact TorHoerman Law for a free, no-obligation case consultation with an experienced Zantac Lawyer.
You can also use our chatbot to receive a free, instant online case evaluation right now.
Which type of Zantac Lawsuit should you file?
If you took Zantac consistently and did not develop cancer, but were unaware of the cancer risks associated with Zantac, you may be eligible to participate in the Zantac CAL.
This lawsuit will likely compensate a percentage of the money you paid over time for Zantac products.
The award will be split evenly amongst class members.
If you took Zantac and were subsequently diagnosed with cancer, you may qualify for a lawsuit.
The Zantac Lawsuit will compensate a percentage of the total damages that you incurred as a result of your cancer diagnosis, including but not limited to:
The award will reflect your personal losses.
TorHoerman Law is currently accepting new clients in the Zantac Cancer Lawsuit.
Our firm is not currently accepting new clients in the Zantac CAL.
A lawsuit has been filed claiming that Zantac containing NDMA caused plaintiffs to develop cancer, which was not a health risk listed on the Zantac warning label.
Before filing a Zantac lawsuit, you should familiarize yourself with the steps of the civil litigation process so that you are aware of the process of a Zantac lawsuit.
Here are five (5) steps you should take when filing a Zantac Lawsuit:
You should do everything possible to mitigate your injuries.
Steps to mitigate damages include:
Mitigation is extremely important in the process of building a strong and honest case with facts.
The first step after mitigation is hiring a personal injury attorney who has experience handling bad drug lawsuits, such as the Zantac Lawsuit.
In the unfortunate event that you are representing a loved one who has died as a result of injuries from Zantac, you may need to consult with a wrongful death attorney who has knowledge of Zantac lawsuits.
Your experienced Zantac Lawsuit lawyer will work to:
The statute of limitations bar the amount of time that an injured party has to take legal action following an injury or accident.
The Zantac Lawsuit Statute of Limitations differ by:
Generally, a Zantac lawsuit plaintiff has 2 years to file a lawsuit following his or her cancer diagnosis.
However, this is not always the case.
It is best to consult with an attorney as soon as possible to determine your Zantac injury statute of limitations.
Evidence will help to prove the total cost of losses that you endured as a result of your injury, also known as your damages.
Your attorney will assist you in gathering evidence, but it is helpful if you start gathering evidence yourself as soon as you find out about your injury.
Common types of evidence in Zantac lawsuits include:
Damages are the total losses, both non-economic and economic, that an injured party incurs as a result of their injury.
In many personal injury lawsuits, the injured party will choose to file for both compensatory damages and punitive damages.
After assessing all damages that you incurred, your Zantac attorney will file a complaint demanding compensation to repay your damages.
Common damages in Zantac Lawsuits include:
At TorHoerman Law, our team of Zantac lawyers is available any time to discuss the Zantac Lawsuits.
We offer free no-obligation case consultations for all potential clients.
Our services are based on contingency fees, so we never charge our clients a dime until they have received compensation first.
With over 100 years in combined litigation experiences and client awards exceeding $4 billion in verdicts & negotiated settlements for litigations we have been involved in - we let our experience and results speak for themselves.
Contact TorHoerman Law to talk to experienced Zantac lawyers and learn about your legal options, including filing a Zantac cancer lawsuit.
Alltucker, Ken. “Zantac Is Prescribed 15 Million Times a Year. So How Did It Become a Potential Cancer Risk?” USA Today, Gannett Satellite Information Network, 10 Nov. 2019, www.usatoday.com/story/news/health/2019/11/07/how-did-zantac-become-potential-cancer-risk-fda-wants-find-out/2509043001/.
Blankenship, Kyle. “Sanofi Takes $186M Hit on the Heels of Zantac Recall.” FiercePharma, Questex LLC, 6 Feb. 2020, www.fiercepharma.com/manufacturing/sanofi-takes-a-big-financial-hit-after-recall-contaminated-zantac.
Curley, M. (n.d.). Zantac Users Push To Consolidate Calif. Cancer Suits. Retrieved July 01, 2020, from https://www.law360.com/articles/1281440/zantac-users-push-to-consolidate-calif-cancer-suits
Johnson, Carolyn Y. “A Tiny Pharmacy Is Identifying Big Problems with Common Drugs, Including Zantac.” The Washington Post, WP Company, 8 Nov. 2019, www.washingtonpost.com/science/a-tiny-pharmacy-is-identifying-big-problems-with-common-drugs-including-zantac/2019/11/08/6dd009ca-eb76-11e9-9c6d-436a0df4f31d_story.html.
Konnath, H. (2020, July 30). Sanofi And GSK Face DOJ Probes Over Zantac Cancer Risk. Retrieved August 02, 2020, from https://www.law360.com/articles/1297127/sanofi-and-gsk-face-doj-probes-over-zantac-cancer-risk
Luhana, Roopal. “Plaintiffs File New Zantac Lawsuits, Claim Drug Caused Colon, Pancreatic Cancer.” New York Injury Law News, The Legal Examiner, 5 July 2020, newyork.legalexaminer.com/health/plaintiffs-file-new-zantac-lawsuits-claim-drug-caused-colon-pancreatic-cancer/.
Luhana, R. (2020, September 15). New Class Action Zantac Lawsuit Includes Claims from Over 200 Zantac Users. Retrieved September 23, 2020, from https://newyork.legalexaminer.com/legal/new-class-action-zantac-lawsuit-includes-claims-from-over-200-zantac-users/
Name Brand Drug Cos. Ax Labeling Claims In Zantac MDL. (n.d.). Retrieved January 12, 2021, from https://www.law360.com/productliability/articles/1343567/name-brand-drug-cos-ax-labeling-claims-in-zantac-mdl?nl_pk=4ea5443d-d995-4317-90cc-b8209e697bbb&utm_source=newsletter&utm_medium=email&utm_campaign=productliability
Office of Regulatory Affairs. “Recalls, Market Withdrawals, & Safety Alerts.” U.S. Food and Drug Administration, FDA, www.fda.gov/safety/recalls-market-withdrawals-safety-alerts.
Palmer, Eric. “Lab Finds NDMA in Zantac Can Develop during Storage.” FiercePharma, 3 Jan. 2020, www.fiercepharma.com/manufacturing/lab-finds-ndma-zantac-can-develop-during-storage-bloomberg.
Sanofi. “Sanofi Delivers Strong Business EPS Growth of 6.8% at CER.” Sanofi, 6 Feb. 2020, www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/2019_Q4_Press_Release_EN.pdf.
Tegna. “New Generic Zantac Recall over Cancer Fear Makes It 3 in Past Week.” WBNS-10TV Columbus, Ohio | Columbus News, Weather & Sports, 13 Nov. 2019, www.10tv.com/article/new-generic-zantac-recall-over-cancer-fear-makes-it-3-past-week-2019-nov.
Turner, T. “Veterans Increasingly Filing Zantac Lawsuits.” November 19, 2020, https://www.consumernotice.org/news/veterans-filing-zantac-lawsuits/
TorHoerman Law was responsible for handling a medical case for our family. I was extremely impressed with their professionalism and ability to react quickly. They also did a nice job keeping us updated with the case throughout the process. This was the first time experiencing a situation like this and Tor Hoerman law did an excellent job from start to finish.
TorHoerman Law is an extraordinary law firm – a firm that truly makes the client’s best interests the primary concern. Their team of personal injury lawyers are experienced, personable, and well versed in a range of litigation areas. They are supported by a dedicated team of staff that are as equally friendly and helpful. I would recommend TorHoerman Law for any personal injury litigation needs.
All of my questions were answered quickly and in a way I could understand. Steve and the entire staff were friendly and professional.
I highly recommend this law firm! The attorneys and staff at THL worked hard, communicated every step of the process, kept me well informed at all times, and exceeded all expectations! The staff is kind, considerate, professional, and very experienced. Look no further, call now!
Top-notch, hardworking attorneys!
A wonderful and professional legal team. They helped me when I needed expert legal representation! Thank you TorHoerman Law!
They contacted me the next day. Very nice people!
The firm went above and beyond. Thank you for everything.
The attorneys at THL were extremely helpful with the legal aspects of setting up my small business.